Baustert Lisa, Boethig Dietmar, Görler Adelheid, Kühn Christian, Weymann Alexander, Schmack Bastian, Popov Aron-Frederik, Ruhparwar Arjang, Wiegmann Bettina
Department for Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Lower Saxony Center for Biomedical Engineering, Implant Research and Development, Hannover Medical School, Hanover, Germany.
CJC Open. 2025 Jan 2;7(4):456-464. doi: 10.1016/j.cjco.2024.12.013. eCollection 2025 Apr.
Because of the increasing importance of quality assurance and individualised patient treatment, EuroSCOREs were analysed for reliability in predicting 30-day mortality in patients with postinfarction ventricular septal rupture (piVSR). To address the specific conditions of patients with piVSR, the Hannover piVSR Score (HpiVSR) was developed.
Between 2001 and 2019, 45 patients with piVSR underwent surgery. Data were collected as necessary for EuroSCORE calculation. Clinically relevant variables were validated for the HpiVSR Score using a nonparsimonious binary logistic regression model. All models were tested for their significant predictive power for 30-day mortality. Their validity was assessed using Hosmer-Lemeshow test and Nagelkerke . Receiver operating characteristic curve and area under the curve were used to illustrate and quantify score accuracy.
The specificity was 77.8% for all EuroSCOREs and 92.6% for the HpiVSR Score, and the sensitivity was in the random range for the EuroSCOREs and 83.3% for the HpiVSR Score. Accordingly, the areas under the curve were 0.676 (95% CI 0.507-0.845) for EuroSCORE II; 0.729 (95% CI 0.581-0.878) and 0.739 (95% CI 0.591-0.886) for the additive and logistic EuroSCORE, respectively; and 0.949 (95% CI 0.891-1.006) for the HpiVSR Score.
The HpiVSR Score enables a more reliable and accurate prediction of 30-day mortality than the EuroSCOREs using 7 significant, objective, reliable, and preoperatively determinable variables. Because of the small sample size of the present study and the fact that only internal validation has been performed so far, the weighting of the factors of the HpiVSR Score can be adjusted after studies with larger patient samples.
由于质量保证和个体化患者治疗的重要性日益增加,对欧洲心脏手术风险评估系统(EuroSCOREs)预测心肌梗死后室间隔破裂(piVSR)患者30天死亡率的可靠性进行了分析。为了满足piVSR患者的特殊情况,开发了汉诺威piVSR评分(HpiVSR)。
2001年至2019年期间,45例piVSR患者接受了手术。收集计算EuroSCORE所需的数据。使用非简约二元逻辑回归模型对HpiVSR评分的临床相关变量进行验证。所有模型均测试其对30天死亡率的显著预测能力。使用Hosmer-Lemeshow检验和Nagelkerke 评估其有效性。采用受试者工作特征曲线和曲线下面积来说明和量化评分准确性。
所有EuroSCOREs的特异性为77.8%,HpiVSR评分为92.6%,EuroSCOREs的敏感性处于随机范围,HpiVSR评分为83.3%。因此,EuroSCORE II的曲线下面积为0.676(95%CI 0.507-0.845);相加式和逻辑EuroSCORE的曲线下面积分别为0.729(95%CI 0.581-0.878)和0.739(95%CI 0.591-0.886);HpiVSR评分的曲线下面积为0.949(95%CI 0.891-1.006)。
HpiVSR评分使用7个显著、客观、可靠且术前可确定的变量,比EuroSCOREs能够更可靠、准确地预测30天死亡率。由于本研究样本量小且目前仅进行了内部验证,在更大患者样本的研究之后,可以调整HpiVSR评分因素的权重。